DouglasWilsonDouglas C Wilson39.74403510000000-104.836059400000009019Wilson, DouglasCClinical Assoc Professor prns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonKennethPetersKenneth S Peters39.74403510000000-104.836059400000009557Peters, KennethClinical Assoc Professor LindseyYatesLindsey Jean Yates39.74403510000000-104.8360594000000012089Yates, LindseyClinical Assoc Professor 1Professor3Asst Professor2Assoc ProfessorAuthorship 165173228611044Sukumar S, Wilson DC, Yu Y, Wong J, Naravula S, Ermakov G, Riener R, Bhagwat B, Necheva AS, Grein J, Churakova T, Mangadu R, Georgiev P, Manfra D, Pinheiro EM, Sriram V, Bailey WJ, Herzyk D, McClanahan TK, Willingham A, Beebe AM, Sadekova SCancer researchSukumar S, Wilson DC, Yu Y, Wong J, Naravula S, Ermakov G, Riener R, Bhagwat B, Necheva AS, Grein J, Churakova T, Mangadu R, Georgiev P, Manfra D, Pinheiro EM, Sriram V, Bailey WJ, Herzyk D, McClanahan TK, Willingham A, Beebe AM, Sadekova S. Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells. Cancer Res. 2017 08 15; 77(16):4378-4388.Cancer Res2017-06-13T00:00:002017Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells.CollisJohnsonCollis Johnson Jr.39.74403510000000-104.8360594000000013192Johnson, CollisAsst Professor-ClinicalAuthorship 168860628854175Peterson VM, Zhang KX, Kumar N, Wong J, Li L, Wilson DC, Moore R, McClanahan TK, Sadekova S, Klappenbach JANature biotechnologyPeterson VM, Zhang KX, Kumar N, Wong J, Li L, Wilson DC, Moore R, McClanahan TK, Sadekova S, Klappenbach JA. Multiplexed quantification of proteins and transcripts in single cells. Nat Biotechnol. 2017 Oct; 35(10):936-939.Nat Biotechnol2017-08-30T00:00:002017Multiplexed quantification of proteins and transcripts in single cells.KevinMcauliffeKevin Mcauliffe39.74403510000000-104.8360594000000013520Mcauliffe, KevinClinical Asst Professor Authorship 185890830097293Bauch? D, Joyce-Shaikh B, Jain R, Grein J, Ku KS, Blumenschein WM, Ganal-Vonarburg SC, Wilson DC, McClanahan TK, Malefyt RW, Macpherson AJ, Annamalai L, Yearley JH, Cua DJImmunityBauch? D, Joyce-Shaikh B, Jain R, Grein J, Ku KS, Blumenschein WM, Ganal-Vonarburg SC, Wilson DC, McClanahan TK, Malefyt RW, Macpherson AJ, Annamalai L, Yearley JH, Cua DJ. LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis. Immunity. 2018 08 21; 49(2):342-352.e5.Immunity2018-08-07T00:00:002018LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis.D018414Anatomy2527150.673827CD8-Positive T-LymphocytesD014124Disorders450.993863Toxoplasmosis, AnimalLeslieBerg/O0TY7S51wjUKQ02eH7WjEJGV5IFBiK9DVE=Leslie Joan Berg39.74545800000000-104.8393691000000015151Berg, LeslieProfessorD014122Living Beings20340.962525ToxoplasmaD061026Chemicals & Drugs1272010.849602Programmed Cell Death 1 ReceptorD018664Chemicals & Drugs601110.939328Interleukin-12SOM-IMM MICRO GENERAL OPERSDM-Dept Restorative DentistrySOM-MEDGastroenterologyInfectious DiseaseUniversity of Colorado Denver - Anschutz Medical CampusRossKedlRoss McNaul Kedl39.74545800000000-104.839369100000002093Kedl, RossProfessorCharlesDinarelloCharles A Dinarello39.74528180000000-104.8375727000000023Dinarello, CharlesDistinguished ProfessorSeanColganSean P Colgan39.74515960000000-104.840628000000002441Colgan, SeanDistinguished ProfessorPhilippaMarrackPhilippa Marrack39.74545800000000-104.839369100000002632Marrack, PhilippaDistinguished ProfessorEthelynThomason LarsenEthelyn Gail Thomason Larsen39.74403510000000-104.836059400000007534Thomason Larsen, EthelynClinical Assoc Professor Authorship 250616834598945Siu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror CClinical cancer research : an official journal of the American Association for Cancer ResearchSiu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror C. First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors. Clin Cancer Res. 2022 01 01; 28(1):57-70.Clin Cancer Res2021-10-01T00:00:002021First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.Authorship 255282834965960Georgiev P, Muise ES, Linn DE, Hinton MC, Wang Y, Cai M, Cadzow L, Wilson DC, Sukumar S, Caniga M, Chen L, Xiao H, Yearley JH, Sriram V, Nebozhyn M, Sathe M, Blumenschein WM, Kerr KS, Hirsch HA, Javaid S, Olow AK, Moy LY, Chiang DY, Loboda A, Cristescu R, Sadekova S, Long BJ, McClanahan TK, Pinheiro EMMolecular cancer therapeuticsGeorgiev P, Muise ES, Linn DE, Hinton MC, Wang Y, Cai M, Cadzow L, Wilson DC, Sukumar S, Caniga M, Chen L, Xiao H, Yearley JH, Sriram V, Nebozhyn M, Sathe M, Blumenschein WM, Kerr KS, Hirsch HA, Javaid S, Olow AK, Moy LY, Chiang DY, Loboda A, Cristescu R, Sadekova S, Long BJ, McClanahan TK, Pinheiro EM. Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models. Mol Cancer Ther. 2022 03 01; 21(3):427-439.Mol Cancer Ther2022-03-01T00:00:002022Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models.Authorship 259511835419588Siu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror CClinical cancer research : an official journal of the American Association for Cancer ResearchSiu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror C. Correction: First-in-Class Anti-Immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors. Clin Cancer Res. 2022 Apr 14; 28(8):1734.Clin Cancer Res2022-04-14T00:00:002022Correction: First-in-Class Anti-Immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.Authorship 271503836106403Siu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror CClinical cancer research : an official journal of the American Association for Cancer ResearchSiu LL, Wang D, Hilton J, Geva R, Rasco D, Perets R, Abraham AK, Wilson DC, Markensohn JF, Lunceford J, Suttner L, Siddiqi S, Altura RA, Maurice-Dror C. Correction: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors. Clin Cancer Res. 2022 Sep 15; 28(18):4158.Clin Cancer Res2022-09-15T00:00:002022Correction: First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.true1Distinguished ProfessorDistinguished Professortrue1Distinguished ProfessorDistinguished Professortrue1Asst Professor-ClinicalAsst Professor-Clinicaltrue1ProfessorProfessortrue1Clinical Assoc Professor Clinical Assoc Professor true1Distinguished ProfessorDistinguished Professortrue1Clinical Asst Professor Clinical Asst Professor true1Clinical Assoc Professor Clinical Assoc Professor true1Clinical Assoc Professor Clinical Assoc Professor true1Clinical Assoc Professor Clinical Assoc Professor true1ProfessorProfessor13065 E 17th Avenue2SODSchool of Dentistry13065 E 17th AvenueAurora80045-2532CO0.7685040.0038077788research areas8.130421.2613660similar to1111selected publicationsAuthorship 1132163Authorship 1132731Authorship 1133515Authorship 113352120023601Chung CS, Venet F, Chen Y, Jones LN, Wilson DC, Ayala CA, Ayala AShock (Augusta, Ga.)Chung CS, Venet F, Chen Y, Jones LN, Wilson DC, Ayala CA, Ayala A. Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival. Shock. 2010 Aug; 34(2):150-61.Shock2010-08-01T00:00:002010Deficiency of Bid protein reduces sepsis-induced apoptosis and inflammation, while improving septic survival.19265156Zhao Y, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, Yap GSJournal of immunology (Baltimore, Md. : 1950)Zhao Y, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, Yap GS. Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages. J Immunol. 2009 Mar 15; 182(6):3775-81.J Immunol2009-03-15T00:00:002009Virulent Toxoplasma gondii evade immunity-related GTPase-mediated parasite vacuole disruption within primed macrophages.20333242Wilson DC, Grotenbreg GM, Liu K, Zhao Y, Frickel EM, Gubbels MJ, Ploegh HL, Yap GSPLoS pathogensWilson DC, Grotenbreg GM, Liu K, Zhao Y, Frickel EM, Gubbels MJ, Ploegh HL, Yap GS. Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog. 2010 Mar 19; 6(3):e1000815.PLoS Pathog2010-03-19T00:00:002010Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells.18424713Wilson DC, Matthews S, Yap GSJournal of immunology (Baltimore, Md. : 1950)Wilson DC, Matthews S, Yap GS. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection. J Immunol. 2008 May 01; 180(9):5935-45.J Immunol2008-05-01T00:00:002008IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection.